Rifaximin tablets are indicated for the treatment of irritable bowel syndrome with diarrhoea (IBS-D) in adults. The tablets ...

Zydus Lifesciences has received tentative approval from the US Food and Drug Administration to market Rifaximin Tablets in ...

Ahmedabad: Pharma major, Zydus Lifesciences Limited, has received tentative approval from the United States Food and Drug ...

The said facility underwent an inspection Between 10-14 March, 2025, and the inspection has been classified as No Action ...

As per the IQVIA data (March, 2025), the Rifaximin tablets had annual sales of $2,672.9 million in the US market.

Zydus Lifesciences Limited has received final approval from the USFDA to manufacture Eluxadoline Tablets, 75 mg and 100 mg, ...

CVS Caremark will add Zydus' Zituvio™ and combination products ... (sitagliptin and metformin hydrochloride) extended-release tablets. These three NDAs of Sitagliptin (base) and combination ...

(Image: Freepik) Zydus Lifesciences rose 3% to an intra-day high of Rs 930 after the company received approval from the US FDA to manufacture Apalutamide Tablets, 60 mg. However, the stock came ...

Zydus Lifesciences Ltd in its press release dated April 11, 2025, stated that it has received US Food and Drug Administration (USFDA) final approval for its Emflaza Tablets generic drug marketed ...

Next, inform Zydus by calling 877-993-8779 ... Anyone considering the use of venlafaxine tablets or any other antidepressant in a child, adolescent, or young adult must balance this risk with ...

Zydus Lifesciences receives USFDA approval for Rifaximin Tablets, a generic treatment for Irritable Bowel Syndrome with ...